Table 4 Outcomes of the AMARIS-SCHWIND 6 th generation excimer laser
From: Excimer laser 6th generation: state of the art and refractive surgical outcomes
Author | Number of patients | Number of eyes | Mean age (years) | Gender (female/male) | MSE (D) | HOA (μm) | Efficacy | Efficacy index | Safety index | Fellow up (months) |
|---|---|---|---|---|---|---|---|---|---|---|
Myopic Patients | ||||||||||
Tomita et al. [16] | 685 | 1280 | 34 ± 8 (18–65) | 371/314 | −4.89 ± 2.12 (−0.5 to −11.63) | 0.66 ± 0.20 | 96.6 % 20/20 | 1.02 | 1.06 | 3 |
94.1% ±0.5 D | ||||||||||
Tomita et al. [17] | 5191 | 10235 | 33.9 ± 7.89 | 2428/2763 | −5.02 ± 2.17 (−2.75 to 11.50) | 0.70 ± 0.23 | 96.9% 0.0 LogMAR | 1 | 1.03 | 3 |
88.4% ±0.5 D | ||||||||||
Vega-Estrada et al. [13] | 17 | 29 | 36.65 ± 10.80 | N/A | −8.39 ± 0.93 | 0.95 ± 0.8 | 89.6% ±1.00 D | NR | Not reported | 6 |
0.11 ± 0.26 LogMAR | ||||||||||
Alió et al. [18] | 32 | 51 | 23-61 | N/A | ≥ − 8.5 | NR | 84.3% ±0.5 D | NR | Not reported | 6 |
Arba-Mosquera et al. [14] | NR | 30 | 33 (19–49) | 53/47 | −4.27 ± 1.62 (−7.38 to −1.38) | 0.425 ± 0.129 (P < 0.01) | 0.47 ± 0.72 lines (P < 0.05) | NR | Not reported | 3 |
−0.07 ± 0.25 (−0.63 to +0.50) | ||||||||||
Hyperopic Patients | ||||||||||
Alió et al. [19] | 28 | 51 | Not reported | NR | +5.64 ± 0.93 (3.50 to 7.88) | −0.44 ± 0.22 (P = 0.00) | 70.37% ±0.5 D | 0.85 | 0.94 | 6 |
Arbelaez et al. [20] | 50 | 100 | 37 (21–59) | 54% Females | +3.02 ± 2.06 (+0.13 to +5.00) +1.36 ± 1.61 (Ast.) (0.00 to 5.00) | ↑ 0.18 (P < 0.05) | 90% 20/20 | 0.89 | 1.1 | 6 |
89% ±0.5 D | ||||||||||
94% ±0.5 (Ast.) | ||||||||||
Astigmatic Patients | ||||||||||
Alió et al. [21] | 36 | 52 | 21-53 | NR | Mixed Ast. > 3.0 | NR | 65.3% ±1.0 D | NR | Not reported | 3 |
Arbelaez et al. [22] | 200 | 360 | NR | NR | −0.14 ± 0.31 | ↑ 0.09 | 97% ±0.5 D | NR | 65% No changes | 6 |
+0.25 ± 0.37 (Ast.) | ||||||||||
Arbelaez et al. [23] | NR | 358 | NR | NR | −3.13 ± 1.58 | ↑ 0.09 | 98% 20/20 | NR | Not reported | 6 |
−0.69 ± 0.67 (Ast.) | 96% ±0.5 D | |||||||||